Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency

NCT00709865 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00709865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00709865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Safety and Tolerability of Intravenous Tonapofylline in Subjects With Acute Decompensated Heart Failure and Renal Insufficiency
Lead sponsor
Biogen
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2008
Completion date
December 31, 2009
Enrollment
420 (actual)
Sites
189

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure, renal insufficiency